Levodopa/Carbidopa Teva

Levodopa, the active ingredient in Levodopa/Carbidopa Teva, is a Antiparkinson agent presented as a tablet for oral use. It treats Parkinson's disease and Parkinsonian syndrome in adults.\nGNH India supplies Levodopa/Carbidopa Teva as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodopa/Carbidopa Teva is used in the management of Parkinsonian disorders and related motor dysfunction.\n\n- Parkinson's disease: improves motor symptoms such as bradykinesia, rigidity and tremor.\n- Parkinsonian syndrome: alleviates motor deficits caused by drug‑induced or secondary Parkinsonism.\n- Motor complications of Parkinsonism: reduces severity of motor fluctuations and off‑periods.

Levodopa/Carbidopa Teva may cause a range of adverse reactions.\n\nCommon Side Effects:\n- Nausea\n- Vomiting\n- Orthostatic hypotension\n- Dizziness\n- Headache\n- Insomnia\n\nSerious or Rare Side Effects:\n- Dyskinesia (involuntary movements)\n- Hallucinations or psychosis\n- Severe hypotension leading to syncope\n- Cardiac arrhythmias\n- Neuroleptic malignant syndrome (rare but life‑threatening).

Levodopa/Carbidopa Teva requires careful monitoring and patient education.\n\n- Blood pressure monitoring: watch for orthostatic drops, especially during dose titration.\n- Renal/hepatic impairment: adjust dose cautiously in patients with reduced organ function.\n- Cardiovascular disease: use with caution in patients with coronary artery disease or arrhythmias.\n- Psychiatric disorders: monitor for emergence of hallucinations or mood changes.\n- Abrupt discontinuation: taper gradually to avoid withdrawal symptoms.\n- Store at ambient temperature: keep in the original pack, protect from moisture.

Levodopa/Carbidopa Teva can interact with several drug classes, requiring vigilance.\n\nMajor Interactions (Avoid):\n- Non‑selective MAO inhibitors (e.g., phenelzine) – risk of hypertensive crisis.\n- Antipsychotics that block dopamine receptors – may diminish therapeutic effect.\n- Sympathomimetic agents (e.g., ephedrine) – may cause severe hypertension.\n\nModerate Interactions (Monitor Closely):\n- Antihypertensive agents – additive blood‑pressure lowering effect.\n- SSRIs or SNRIs – potential for serotonin syndrome when combined with MAO‑B inhibitors.\n- Iron or vitamin B6 supplements – may reduce levodopa absorption; separate dosing by at least 2 hours.